Viewing Study NCT02219503

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:47 PM
Ignite Modification Date: 2026-05-19 @ 4:00 AM
Study NCT ID: NCT02219503
Status: COMPLETED
Last Update Posted: 2021-07-12
First Post: 2014-08-15
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
Sponsor: AbbVie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Hepatitis C Infection View
None Compensated Cirrhosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatitis C View
None Chronic Hepatitis C View
None Compensated Cirrhosis View
None Cirrhotic View
None Hepatitis C Genotype 1b View
None Hepatitis C Virus View
None Interferon-Free View
None Child Pugh A View
None Ribavirin-Free View